| HAND2 |
HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
| MAX |
MAX: Protein max |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
| KRTAP10-8 |
KRTAP10-8, KAP10.8, KAP18-8, KRTAP10.8, KRTAP18-8, KRTAP18.8: Keratin-associated |
TNFSF18 |
TNFSF18, AITRL, UNQ149/PRO175, GITRL, TL6: Tumor necrosis factor ligand superfam |
0.265 |
Evidence |
|
| KRTAP12-4 |
KRTAP12-4, KAP12.4, KRTAP12.4: Keratin-associated protein 12-4 |
TNFSF18 |
TNFSF18, AITRL, UNQ149/PRO175, GITRL, TL6: Tumor necrosis factor ligand superfam |
0.265 |
Evidence |
|
| C20orf186 |
LPLUNC4, C20orf186: Long palate, lung and nasal epithelium carcinoma-associated |
APOA5 |
APOA5, RAP3, UNQ411/PRO773: Apolipoprotein A-V precursor |
0.265 |
Evidence |
|
| C20orf185 |
C20orf185, LPLUNC3: Long palate, lung and nasal epithelium carcinoma-associated |
APOA5 |
APOA5, RAP3, UNQ411/PRO773: Apolipoprotein A-V precursor |
0.265 |
Evidence |
|
| NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| NALP12 |
NLRP12, NALP12, PYPAF7, RNO: NACHT, LRR and PYD domains-containing protein 12 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| NALP11 |
NLRP11, NALP11, NOD17, PYPAF6: NACHT, LRR and PYD domains-containing protein 11 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| NALP6 |
NLRP6, NALP6, PYPAF5: NACHT, LRR and PYD domains-containing protein 6 |
AIM2 |
AIM2: AIM2 protein |
0.265 |
Evidence |
|
| NALP6 |
NLRP6, NALP6, PYPAF5: NACHT, LRR and PYD domains-containing protein 6 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| ICEBERG |
ICEBERG, UNQ5804/PRO19611: Caspase-1 inhibitor Iceberg |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| SCAND1 |
SCAND1, SDP1: SCAN domain-containing protein 1 |
ZNF132 |
ZNF132: Zinc finger protein 132 |
0.265 |
Evidence |
|
| SCAND1 |
SCAND1, SDP1: SCAN domain-containing protein 1 |
ZNF615 |
DKFZp686O1554: Putative uncharacterized protein DKFZp686O1554 |
0.265 |
Evidence |
|
| SCAND1 |
SCAND1, SDP1: SCAN domain-containing protein 1 |
ZNF214 |
ZNF214, BAZ1: Zinc finger protein 214 |
0.265 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BCL2L13 |
BCL2L13, MIL1, CD003: Bcl-2-like 13 protein |
0.265 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BAX |
BAX: Apoptosis regulator BAX, membrane isoform alpha |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BOK |
BOK: Bcl-2-related ovarian killer protein |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BAX |
BAX: Apoptosis regulator BAX, membrane isoform alpha |
0.265 |
Evidence |
|
| BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BID |
BID: BH3-interacting domain death agonist |
0.265 |
Evidence |
|
| CASP9 |
CASP9, MCH6: Caspase-9 precursor |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|